Table 1.
Baseline characteristics.
| Variable | Mean | SD |
|---|---|---|
| A: Continuous variables | ||
| uKIM/Cr (ng/mmol) | 121.4 | 10.2 |
| uNGAL/Cr (ng/mmol) | 2050.4 | 261.4 |
| uCyst/Cr (ng/mmol) | 14.0 | 0.003 |
| Age (years) | 77.8 | 0.17 |
| Systolic blood pressure (mmHg) | 152 | 4.43 |
| Total cholesterol (mmol/L) | 5.15 | 0.14 |
| HDL(mmol/L) | 1.16 | 0.04 |
| BMI (kg/m2) | 27.3 | 0.53 |
| HbA1c (Mono S, %) | 5.8 | 0.12 |
| GFR-cyst (mL/min/1.73 m2) | 73.5 | 2.5 |
| uACR (mg/mmol) | 1.5 | 0.33 |
| n | % | |
| B: Categorical variables | ||
| Smoking | 4 | 4 |
| Hypertension treatment | 61 | 67 |
| Lipid-lowering treatment | 23 | 25 |
| Diabetes treatment | 47 | 52 |
| Previous CVD | 7 | 8 |
| Atrial fibrillation | 12 | 14 |
| Microalbuminuria | 33 | 36 |
| Chronic kidney disease | 20 | 22 |
BMI: body mass index; GFR: glomerular filtration rate; HDL: high-density lipoprotein; previous CVD: previous cardiovascular disease events; uACR: urinary albumin–creatinine ratio; uCystC/Cr: urinary cystatin C–creatinine ratio; uKIM-1/Cr: urinary kidney injury molecule-1–creatinine ratio; uNGAL/Cr: urinary neutrophil gelatinase-associated lipocalin–creatinine ratio.